The UK Tobacco and Vapes Bill represents a landmark moment in tobacco control, positioning the UK as a global leader in efforts to reduce smoking-related harm. By introducing measures to create a smoke-free generation – preventing the next generation from ever legally purchasing tobacco (the Bill will make it illegal to sell cigarettes to anyone born on or after 1 January 2009) – the Bill addresses the root cause of premature death, disease, poverty, health inequalities and social injustice. For organisations like the British Thoracic Oncology Group (BTOG), this legislation is particularly significant given tobacco is the single greatest cause of preventable cancers and lung cancer remains the leading cause of cancer death in the UK.
The Bill’s importance lies not only in its preventative ambition but also in its potential to reduce health inequalities. Smoking rates remain disproportionately high in the most disadvantaged communities, including those living in poverty and those living with mental health illness, contributing to stark disparities in cancer incidence and outcomes. By preventing access to tobacco, over time this will lead to fewer diagnoses of lung cancer, other cancers, and other smoking-related diseases, easing pressure on NHS services and improving population health.
The Bill also strengthens regulation around vaping products, to make them less appealing and less accessible to young people, whilst maintaining their important role as a highly effective treatment for tobacco dependency.
BTOG Steering Committee Member, Professor Matthew Evison, Consultant Physician in Respiratory Medicine (Thoracic Oncology) at North West Lung Centre and University of Manchester, said: “The long-term impact of this legislation could be transformative by truly making tobacco obsolete, banishing it to the history of this country. A smokefree generation will be one that enjoys fewer cancer cases, improved survival rates, and reduced healthcare costs. The Tobacco and Vapes Bill signals a decisive shift towards prevention-focused policy, reinforcing the UK’s commitment to tackling the burden of tobacco-related disease and advancing progress towards a smoke-free future.”
BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London, said: “BTOG recognises that the impact for future generations of this Bill is substantial and this is a cause for celebration. However, there remains a great challenge to provide comprehensive treatment and support to anyone who currently smokes tobacco. Treating tobacco dependency is a fundamental pillar of healthcare and should be delivered within every aspect of the NHS.”
